Lymphadenopathy after COVID-19 vaccine mimicking lymph-node progression in a patient with metastatic melanoma

Julia Verdaguer Faja; Josè Luis Manzano; Sofia  España; Paula Cecilia Notta; Raul Vicente Rodriguez Iniesta; Aram Boada

doi:10.5826/dpc.1204a171

Lymphadenopathy after COVID-19 vaccine mimicking lymph-node progression in a patient with metastatic melanoma

Authors

Julia Verdaguer Faja a:1:{s:5:"en_US";s:43:"Hospital Universitari Germans Trias i Pujol";}
Josè Luis Manzano Medical Oncology Department. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Badalona, Barcelona, España.
Sofia España Medical Oncology Department. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Badalona, Barcelona
Paula Cecilia Notta Nuclear Medicine-PET Department. Hospital Universitari de Bellvitge. Universitat de Barcelona. Hospitalet de Llobregat, Barcelona, España.
Raul Vicente Rodriguez Iniesta Radiology Department. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Badalona, Barcelona, España.
Aram Boada Dermatology Department. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Badalona, Barcelona; Institut Investigació Germans Trias i Pujol (IGTP)

Keywords:

melanoma, adenopathy, lymphadenopathy, COVID-19, vaccination

References

1. Cohen D, Krauthammer SH, Wolf I, Even-Sapir E. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation. Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1854-1863. doi: 10.1007/s00259-021-05314-2. Epub 2021 Mar 27. PMID: 33774684; PMCID: PMC8003894.
2. Skawran S, Gennari AG, Dittli M, et al. [18F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impact. Eur Radiol. 2021 Jun 22:1–9. doi: 10.1007/s00330-021-08122-2. Epub ahead of print. PMID: 34156552; PMCID: PMC8217971.
3. Thomassen A, Lerberg Nielsen A, Gerke O, Johansen A, Petersen H. Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination. Eur J Nucl Med Mol Imaging. 2011 May;38(5):894-8. doi: 10.1007/s00259-011-1729-9. Epub 2011 Feb 22. PMID: 21340453.
4. McIntosh LJ, Bankier AA, Vijayaraghavan GR, Licho R, Rosen MP. COVID-19 vaccination-related uptake on FDG PET/CT: An emerging dilemma and suggestions for management. Am J Roentgenol. 2021 Oct;217(4):975-983. doi: 10.2214/AJR.21.25728. Epub 2021 Mar 1. PMID: 33646823.
5. McIntosh LJ, Rosen MP, Mittal K, et al. Coordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination. Cancer Treat Rev. 2021 Jul;98:102220. doi: 10.1016/j.ctrv.2021.102220. Epub 2021 May 11. PMID: 34029956; PMCID: PMC8110324.